Evidence map›Paper›PMID 40740325›Full record

ArticleFrontiers in microbiology2025

Revisiting phage tail spike architecture: evidence for undetected receptor-binding proteins in

Rafał Matusiak, Magdalena Antczak, Anna Kawa, Małgorzata Paszkiewicz, Jolanta Witaszewska, Joanna Kazimierczak, Ewelina A Wójcik

Abstract read
In one paragraph

Article in Frontiers in microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. F-Type Pyocin Versus Phage λ Tail: Conserved Hub, Divergent Fibers.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  3. Article
  4. Genome-based taxonomic classification ofFrontiers in microbiology · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Rafał MatusiakResearch and Development, Proteon Pharmaceuticals S.A., Łódź, Poland.
Magdalena AntczakResearch and Development, Proteon Pharmaceuticals S.A., Łódź, Poland.
Anna KawaResearch and Development, Proteon Pharmaceuticals S.A., Łódź, Poland.
Małgorzata PaszkiewiczResearch and Development, Proteon Pharmaceuticals S.A., Łódź, Poland.
Jolanta WitaszewskaResearch and Development, Proteon Pharmaceuticals S.A., Łódź, Poland.
Joanna KazimierczakResearch and Development, Proteon Pharmaceuticals S.A., Łódź, Poland.
Ewelina A WójcikResearch and Development, Proteon Pharmaceuticals S.A., Łódź, Poland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Bacteriophages, viruses that infect bacterial cells, have garnered renewed interest as potential therapeutic agents due to the growing threat of antibiotic resistance. Effective application of bacteriophages requires a comprehensive understanding of their structure and mechanisms of action. Recent advances in structural biology techniques, such as cryo-electron microscopy (Cryo-EM) and cryo-electron tomography (Cryo-ET), along with significant progress in genome sequencing and bioinformatics, have greatly enhanced our knowledge of bacteriophage biology. However, these techniques remain insufficient in some cases to fully resolve the structure and function of phage tail spikes and tail fibers. Methods: This study investigates the receptor-binding proteins (RBPs) of bacteriophages within the Results: Our findings indicate that phages from the genera Discussion: These results suggest that the analysed phages possess an additional, previously unidentified protein at the tip of the tail spike, which likely facilitates interaction with receptor proteins on the bacterial cell surface.

Indexed as

bacteriophagesreceptor binding proteinreceptor recognition mechanismsstructural bioinformaticstail spike

Identifiers

PMID40740325
PMCPMC12309495

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.